TotalEnergies secures two offshore exploration permits in Nigeria

Patrick Pouyanné Chairman and Chief Executive Officer TotalEnergies SE
Patrick Pouyanné Chairman and Chief Executive Officer - TotalEnergies SE
0Comments

TotalEnergies and South Atlantic Petroleum have signed a Production Sharing Contract for two offshore exploration licenses, PPL 2000 and PPL 2001, in Nigeria. TotalEnergies holds an 80% stake and operates the blocks, while South Atlantic Petroleum holds the remaining 20%. The permits were awarded following the 2024 Exploration Round organized by the Nigerian Upstream Petroleum Regulatory Commission.

The exploration blocks cover about 2,000 square kilometers in the West Delta basin. The initial work program includes drilling one firm exploration well.

“TotalEnergies is honored to be the first international company to be awarded exploration licenses in a bid round in Nigeria in more than a decade, marking a new milestone in our long-term partnership with the country,” said Kevin McLachlan, Senior Vice-President Exploration at TotalEnergies. “These promising block captures are fully aligned with our strategy of strengthening our Exploration portfolio with drill-ready and high impact prospects, that have the potential for low-cost and low-emissions developments from new discoveries in our core areas of expertise.”

TotalEnergies has operated in Nigeria for over sixty years and employs more than 1,800 people across various business segments. In 2024, Nigeria contributed significantly to TotalEnergies’ hydrocarbon production with an output of 209,000 barrels of oil equivalent per day. The company also manages a distribution network that includes around 540 service stations nationwide. TotalEnergies states it is committed to supporting socio-economic development and working with local communities.

Globally, TotalEnergies is active in about 120 countries and employs over 100,000 people. The company’s operations span oil, biofuels, natural gas, biogas, low-carbon hydrogen, renewables and electricity.

###



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.